CatalystAlert vs BioMarkets.io
Both track biotech catalysts. BioMarkets.io A professional biotech & pharma pipeline-intelligence platform — ML probability-of-approval with confidence intervals, 10,000+ drugs, and 13F institutional tracking, positioned as a lower-cost Bloomberg/FactSet alternative. CatalystAlert CatalystAlert is a biotech catalyst intelligence platform tracking FDA decisions, PDUFA dates, and clinical-trial readouts for 1,600+ biotech stocks. Every catalyst date carries a confidence rating — confirmed against an official regulatory source, estimated, or AI-detected — alongside AI entry-timing and a public, scored prediction track record.
| Capability | CatalystAlert | BioMarkets.io |
|---|---|---|
| FDA / PDUFA catalyst calendar | ||
| Per-date source-confidence labels | ||
| AI likelihood-of-approval (LOA) | ||
| AI entry-timing (pre-catalyst run-up) | ||
| Quantified per-event trade score | ||
| Institutional / 13F smart-money | ||
| Plain-English trial analysis | ||
| AI portfolio generation | ||
| Public, scored prediction track record | ||
| Free tier |
= verified on the tool's public site · = not advertised / not verified (check their site) · = not offered. Verified 2026-05-31; features & pricing change — confirm on each site. Corrections welcome.
- Institutional-grade depth: 10,000+ drugs, target/disease databases, valuation tooling.
- ML approval-probability with confidence intervals calibrated to FDA outcomes.
- 13F hedge-fund positioning analysis for tracking institutional accumulation.
- Per-date confidence labels — every catalyst date is marked confirmed (official regulatory source), estimated, or AI-detected, so you know how reliable each date is.
- AI entry-timing — a run-up conviction score for the pre-catalyst window, not just the event date.
- A public, scored prediction track record (likelihood-of-approval, stock-impact, entry-timing) measured against actual outcomes.
- Breadth: 1,600+ biotech & pharma companies and tens of thousands of tracked catalysts.
CatalystAlert: Free tier (calendar, watchlist, weekly digest); Pro $29.99/mo (full calendar, AI predictions, alerts, smart-money); Elite $99.99/mo (API).
BioMarkets.io: Paid, month-to-month, cancel anytime. Confirm current pricing on their site.
We aim for a fair comparison: details about BioMarkets.io were taken from biomarkets.io on 2026-05-31. If anything is out of date, the source of truth is their own site.
FAQ
Is CatalystAlert a good alternative to BioMarkets.io?
CatalystAlert and BioMarkets.io both track biotech catalysts (FDA decisions, PDUFA dates, clinical-trial readouts). BioMarkets.io is strongest at: institutional-grade depth: 10,000+ drugs, target/disease databases, valuation tooling. CatalystAlert adds per-date confidence labels (confirmed / estimated / AI-detected), AI entry-timing for the pre-catalyst run-up, and a public, scored prediction track record. Which fits depends on whether you want BioMarkets.io's focus or CatalystAlert's verifiability and entry-timing.
What does CatalystAlert add compared to BioMarkets.io?
Entry-timing for the pre-catalyst run-up and a public, scored prediction track record. Per-date confidence labels and a retail-trader-first calendar UX, not just analyst tooling.
How much do CatalystAlert and BioMarkets.io cost?
CatalystAlert: Free tier (calendar, watchlist, weekly digest); Pro $29.99/mo (full calendar, AI predictions, alerts, smart-money); Elite $99.99/mo (API). BioMarkets.io: Paid, month-to-month, cancel anytime. Confirm current pricing on their site.
Where do CatalystAlert's catalyst dates come from?
Every catalyst date carries a confidence label: "confirmed" (verified against an official regulatory source), "estimated" (e.g. ClinicalTrials.gov), or "AI-detected" (extracted from news, flagged to verify). Sources include FDA, SEC EDGAR and ClinicalTrials.gov.
See CatalystAlert's catalyst calendar
Sourced FDA & PDUFA dates with confidence labels, AI entry-timing, and a public track record.